Zobrazeno 1 - 10
of 353
pro vyhledávání: '"M. Slee"'
Autor:
M. Lefort, S. Sharmin, J. B. Andersen, S. Vukusic, R. Casey, M. Debouverie, G. Edan, J. Ciron, A. Ruet, J. De Sèze, E. Maillart, H. Zephir, P. Labauge, G. Defer, C. Lebrun-Frenay, T. Moreau, E. Berger, P. Clavelou, J. Pelletier, B. Stankoff, O. Gout, E. Thouvenot, O. Heinzlef, A. Al-Khedr, B. Bourre, O. Casez, P. Cabre, A. Montcuquet, A. Wahab, J. P. Camdessanché, A. Maurousset, H. Ben Nasr, K. Hankiewicz, C. Pottier, N. Maubeuge, D. Dimitri-Boulos, C. Nifle, D. A. Laplaud, D. Horakova, E. K. Havrdova, R. Alroughani, G. Izquierdo, S. Eichau, S. Ozakbas, F. Patti, M. Onofrj, A. Lugaresi, M. Terzi, P. Grammond, F. Grand’Maison, B. Yamout, A. Prat, M. Girard, P. Duquette, C. Boz, M. Trojano, P. McCombe, M. Slee, J. Lechner-Scott, R. Turkoglu, P. Sola, D. Ferraro, F. Granella, V. Shaygannejad, J. Prevost, D. Maimone, O. Skibina, K. Buzzard, A. Van der Walt, R. Karabudak, B. Van Wijmeersch, T. Csepany, D. Spitaleri, S. Vucic, N. Koch-Henriksen, F. Sellebjerg, P. S. Soerensen, C. C. Hilt Christensen, P. V. Rasmussen, M. B. Jensen, J. L. Frederiksen, S. Bramow, H. K. Mathiesen, K. I. Schreiber, H. Butzkueven, M. Magyari, T. Kalincik, E. Leray
Publikováno v:
BMC Medical Research Methodology, Vol 22, Iss 1, Pp 1-14 (2022)
Abstract Background Natalizumab and fingolimod are used as high-efficacy treatments in relapsing–remitting multiple sclerosis. Several observational studies comparing these two drugs have shown variable results, using different methods to control t
Externí odkaz:
https://doaj.org/article/84c3797631444a10b4fb616e78d4bf21
Autor:
Ruben A. Mesa, Erin M. Sullivan, David Dubinski, Brittany Carroll, Valerie M. Slee, Susan V. Jennings, Celeste C. Finnerty, Linda S. Bohannon, Susan D. Mathias, Betsy J. Lahue, Mariana C. Castells
Publikováno v:
Cancer. 128:3691-3699
Autor:
Susan V. Jennings, Celeste C. Finnerty, Jessica S. Hobart, Mercedes Martín-Martínez, Kristin A. Sinclair, Valerie M. Slee, Julie Agopian, Cem Akin, Ivan Álvarez-Twose, Patrizia Bonadonna, Angela S. Bowman, Knut Brockow, Horia Bumbea, Claudia de Haro, Jie Shen Fok, Karin Hartmann, Nicole Hegmann, Olivier Hermine, Monika Kalisiak, Constance H. Katelaris, Jacqueline Kurz, Patrizia Marcis, David Mayne, David Mendoza, Alain Moussy, Genija Mudretzkyj, Nicoleta Nidelea Vaia, Marek Niedoszytko, Hanneke Oude Elberink, Alberto Orfao, Deepti H. Radia, Sophie Rosenmeier, Eugenia Ribada, Waltraud Schinhofen, Juliana Schwaab, Frank Siebenhaar, Massimo Triggiani, Giuseppe Tripodo, Rocio Velazquez, Yvon Wielink, Friedrich Wimazal, Timo Yigit, Celia Zubrinich, Peter Valent
Publikováno v:
Journal of Allergy and Clinical Immunology: In Practice, 10(8), 2039-2051. American Academy of Allergy, Asthma and Immunology
Background: Since 2010, patients and physicians have collaborated to understand unmet needs of patients with mast cell diseases, incorporating mastocytosis and mast cell activation disorders, which include mast cell activation syndromes. Objective: T
Publikováno v:
Annals of Allergy, Asthma & Immunology. 127:407-409
Autor:
Ruben A. Mesa, Erin M. Sullivan, David Dubinski, Brittany Carroll, Valerie M. Slee, Susan V. Jennings, Celeste C. Finnerty, Linda S. Bohannon, Susan D. Mathias, Betsy J. Lahue, Mariana C. Castells
Publikováno v:
Cancer. 128(20)
Systemic mastocytosis (SM) is a rare clonal neoplasm driven by the KIT D816V mutation and has a broad range of debilitating symptoms. In this study, the authors evaluated SM disease perceptions and management strategies among US health care providers
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Annals of allergy, asthmaimmunology : official publication of the American College of Allergy, Asthma,Immunology. 127(4)
Autor:
Mercedes Martín-Martínez, Valerie M. Slee, Lisa Morrison Thuler, Shawna L. Lechner-Rumpel, David W. Mayne, Jessica Hobart, Susan V. Jennings
Publikováno v:
Mastocytosis ISBN: 9783030278229
Support for patients, caregivers, and families affected by mast cell disease, from healthcare providers, patient associations collaborating on an international level, and online forums, can offer key mechanisms through which disease management can be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cfbae3c92e23c3718573d98611af5459
https://doi.org/10.1007/978-3-030-27820-5_16
https://doi.org/10.1007/978-3-030-27820-5_16
Autor:
Kevin M. Krause, Wright W. Nichols, Peter J. Laud, Eric Gangl, Petar Pop-Damkov, Taryn Sleger, Andrew M Slee
Publikováno v:
Journal of Chemotherapy. 30:95-100
Efficacies of ceftazidime-avibactam (4:1 w/w) and ceftazidime were tested against ceftazidime-susceptible (blaKPC-2-negative), and meropenem- and ceftazidime-resistant (blaKPC-2-positive), Klebsiella pneumoniae in a 52-h, multiple dose, abdominal abs
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.